All In MedTech

Device Trial Radar · NCT04203810

Effectiveness and Tolerability of Ectoin® Mouth and Throat Spray Althaea Honey (ERS09)

Effectiveness and Tolerability of Ectoin® Mouth and Throat Spray Althaea Honey (ERS09) Compared to Saline Spray in Patients Suffering From Sore Throat Due to Acute Pharyngitis and Dry Cough

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 194 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

194

Actual

Start

Jan 14, 2020

Primary completion

Dec 4, 2020

Study completion Dec 4, 2020

Sponsor

Lead sponsor
Bitop AGNot on our public-company list
Sponsor type
Industry
First posted
Dec 18, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this multicentre, actively controlled, randomized, open label, parallel group, prospective, comparator study is to collect data on the clinical effectiveness and tolerability of the medical device ERS09 compared to a well-established comparator spray in the symptomatic treatment of sore throat due to acute pharyngitis and dry cough.

Conditions

  • Sore Throat
  • Acute Pharyngitis
  • Cough

Interventions

  • Ectoin® Mouth and Throat Spray Althaea Honey (ERS09)Device

    4 puffs to be administered as needed several times a day for patients aged ≥ 12 years. A maximum of 10 applications per day should not be exceeded.

  • EMSER® Hals-und Rachenspray (throat spray)Device

    1 to 3 puffs to be administered several times a day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of mean total symptom scoreTime frame: 7 days
  2. Change of daily symptom scoreTime frame: 1 day

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Dr. Pasch

    Aachen, Germany

  • Dr. Sondermann

    Aachen, Germany

  • Dr. Männer

    Arnsberg, Germany

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.